Farther Finance Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.84K | Buy |
1,660
+1,435
| +638% | +$6.77K | ﹤0.01% | 3191 |
|
|
2025
Q1 | $1.01K | Sell |
225
-303
| -57% | -$1.36K | ﹤0.01% | 3610 |
|
|
2024
Q4 | $2.53K | Hold |
528
| – | – | ﹤0.01% | 2912 |
|
|
2024
Q3 | $2.48K | Buy |
528
+48
| +10% | +$225 | ﹤0.01% | 2913 |
|
|
2024
Q2 | $2.68K | Buy |
480
+287
| +149% | +$1.6K | ﹤0.01% | 2670 |
|
|
2024
Q1 | $795 | Sell |
193
-262
| -58% | -$1.08K | ﹤0.01% | 2861 |
|
|
2023
Q4 | $1.92K | Buy |
455
+297
| +188% | +$1.25K | ﹤0.01% | 2445 |
|
|
2023
Q3 | $683 | Sell |
158
-23
| -13% | -$99 | ﹤0.01% | 2183 |
|
|
2023
Q2 | $1.19K | Buy |
181
+23
| +15% | +$152 | ﹤0.01% | 1915 |
|
|
2023
Q1 | $1.07K | Sell |
158
-48
| -23% | -$326 | ﹤0.01% | 1826 |
|
|
2022
Q4 | $1.52K | Buy |
+206
| New | +$1.52K | ﹤0.01% | 1539 |
|